An ethical analysis of policy dialogues.

BACKGROUND: A policy dialogue is a tool which promotes evidence-informed policy-making. It involves deliberation about a high-priority issue, informed by a synthesis of the best-available evidence, where potential policy interventions are discussed by stakeholders. We offer an ethical analysis of policy dialogues - an argument about how policy dialogues ought to be conceived and executed - to guide those organizing and participating in policy dialogues. Our analysis focuses on the deliberative dialogues themselves, rather than ethical issues in the broader policy context within which they are situated. METHODS: We conduct a philosophical conceptual analysis of policy dialogues, informed by a formal and an interpretative literature review. RESULTS: We identify the objectives of policy dialogues, and consider the procedural and substantive values that should govern them. As knowledge translation tools, the chief objective of policy dialogues is to ensure that prospective evidence-informed health policies are appropriate for and likely to support evidence-informed decision-making in a particular context. We identify five core characteristics which serve this objective: policy dialogues are (i) focused on a high-priority issue, (ii) evidence-informed, (iii) deliberative, (iv) participatory and (v) action-oriented. In contrast to dominant ethical frameworks for policy-making, we argue that transparency and accountability are not central procedural values for policy dialogues, as they are liable to inhibit the open deliberation that is necessary for successful policy dialogues. Instead, policy dialogues are legitimate insofar as they pursue the objectives and embody the core characteristics identified above. Finally, we argue that good policy dialogues need to actively consider a range of substantive values other than health benefit and equity. CONCLUSIONS: Policy dialogues should recognize the limits of effectiveness as a guiding value for policy-making, and operate with an expansive conception of successful outcomes. We offer a set of questions to support those organizing and participating in policy dialogues.

Estonia: Health System Review.

This analysis of the Estonian health system illustrates recent developments in organization and governance, health financing, health care provision, health reforms and health system performance. In general, Estonia spends less per capita on health than the European Union average, although public expenditure has been growing steadily, with an increasing role of government budget transfers towards the social health insurance model. Despite these efforts, more than a fifth of current health expenditure comes from out-of-pocket payments, creating pressure to develop new and strengthen existing financial protection instruments. Life expectancy in Estonia has increased rapidly over the past decade, but not fast enough to meet the targets set in strategic documents. The first years of the COVID-19 pandemic were marked by a decline in life expectancy and high excess mortality, which set back progress. Despite this, Estonia's gains in population health were more pronounced in 2022. Overall, health inequalities between socioeconomic groups remain high, prompting policymakers to take steps to increase equity in access to care. The outstanding challenges for the Estonian health system include: addressing the shortage of primary and mental health experts, especially given the growing burden of chronic conditions and other needs of the ageing population; minimizing stark socioeconomic inequalities in health outcomes; renewing the outdated public health framework; and further improving integration and coordination of care and clinical decision-making.

The ecosystem of health decision making: from fragmentation to synergy.

Clinicians, patients, policy makers, funders, programme managers, regulators, and science communities invest considerable amounts of time and energy in influencing or making decisions at various levels, using systematic reviews, health technology assessments, guideline recommendations, coverage decisions, selection of essential medicines and diagnostics, quality assurance and improvement schemes, and policy and evidence briefs. The criteria and methods that these actors use in their work differ (eg, the role economic analysis has in decision making), but these methods frequently overlap and exist together. Under the aegis of WHO, we have brought together representatives of different areas to reconcile how the evidence that influences decisions is used across multiple health system decision levels. We describe the overlap and differences in decision-making criteria between different actors in the health sector to provide bridging opportunities through a unifying broad framework that we call theory of everything. Although decision-making activities respond to system needs, processes are often poorly coordinated, both globally and on a country level. A decision made in isolation from other decisions on the same topic could cause misleading, unnecessary, or conflicted inputs to the health system and, therefore, confusion and resource waste.

A comprehensive monitoring and evaluation framework for evidence to policy networks.

OBJECTIVE: To describe the development of a framework for monitoring and evaluating knowledge translation (KT) networks. METHOD: The framework was developed using mixed methods over four phases, including i) a targeted literature review of KT networks, activities and indicators, ii) two scoping reviews to further enhance the set of indicators, iii) peer-reviews by international KT experts and an online expert consultation, and iv) piloting. RESULTS: A comprehensive theory of change (ToC) and indicators, both for the Network Secretariat and its participating member countries, were identified to develop the monitoring and evaluation framework. The framework includes (i) a ToC, including three key indicator domains across the results chain (outputs, short term outcomes, intermediate outcomes), and (ii) indicators for the three key domains, that can be selected depending on the stage of network maturity, along with suggested data collection methods. The three key indicator domains are 1) KT capacity and skill building; 2) network (structure, governance and leadership); and 3) KT/evidence-informed policy value and culture. CONCLUSION: The monitoring and evaluation framework that links KT activities with policy and health outcomes fills an important gap in optimizing KT procedures, generating lessons learned and increasing accountability of major multipartner KT networks.

The 2017 reform to improve financial sustainability of national health insurance in Estonia: Analysis and first lessons on broadening the revenue base.

In 2017, the Estonian government addressed the longstanding challenge of financial sustainability of the health system by expanding its revenue base. As a relatively low-spending country on health, Estonia relies predominantly on payroll contributions from the working population, which exposes the system to economic shocks and population ageing. In an effort to reduce these vulnerabilities, Estonia will gradually introduce a government transfer on behalf of pensioners, although long-term sustainability of the health system could still prove challenging as the overall health spending as a percentage of GDP is not expected to substantially increase. Estonia has rolled out the reform according to plan, but it has led to debate about the need to achieve universal population coverage (currently at about 95%). Moreover, the Estonian experience also holds important lessons for other countries looking to reform their health system. For example, policymakers should recognize that reforms require extensive preparation using consistent messaging over a long period of time, also to prevent prioritising short term and popular fixes over structural reforms. Additionally, collaboration between the health and financial ministries throughout the reform increases the buy-in for the reform and likelihood of adoption. Furthermore, health professionals play a significant role in advocacy, and seeking support from this group can smooth the path towards health system reform.

Estonia: Health System Review.

This analysis of the Estonian health system reviews recent developments in organization and governance, health financing, health care provision, health reforms and health system performance. In 2017, the Estonian government took the historic step of expanding the revenue base of the health system, which has been a longstanding challenge. However, in terms of percentage of GDP it remains a small increase and long-term financial sustainability could still pose a problem. That said, if these additional funds are invested wisely, they could play a positive role in further improving the health system. Indeed, although Estonia has made remarkable progress on many health indicators (e.g. the strongest gains in life expectancy of all EU countries, strongly falling amenable mortality rates), there are opportunities for improvements. They include overcoming the large health disparities between socioeconomic groups, improving population coverage, developing a comprehensive plan to tackle workforce shortages, better managing the growing number of people with (multiple) noncommunicable diseases and further reaping the benefits of the e-health system, especially for care integration and clinical decision-making. Also in terms of quality, large strides have been made but the picture is mixed. Avoidable hospital admissions are among the lowest in Europe for asthma and chronic obstructive pulmonary disease (COPD), about average for congestive heart failure and diabetes, but among the worst for hypertension. Moreover, the 30-day fatality rates for acute myocardial infarction and stroke are among the worst in the EU. These outcomes suggest substantial room to further improve service quality and care coordination. The new NHP, which is currently being revised will be play a crucial role in the success of future reform efforts.

Eesti: tervisesüsteemi ülevaade

Eesti tervisesüsteemi analüüs käsitleb viimast arengut tervisesüsteemi korralduses,juhtimises ja rahastamises, tervishoiuteenuste osutamises, tervisesüsteemireformides ja tulemuslikkuses. Eesti valitsus astus 2017. aastal ajaloolisesammu ja laiendas tervisesüsteemi tulubaasi, mis on pikka aega olnudprobleem. Lisanduv raha on protsendina SKPst siiski väike ning pikaajalisestabiilsuse saavutamine võib endiselt jääda probleemiks. Kui lisaraha investeeritaksetargalt, võib see tervisesüsteemi täiustamisele positiivselt mõjuda.Ehkki Eestis on paljud tervisenäitajad oluliselt paranenud (nt oodatava elueasuurim pikenemine kõigist ELi riikidest, välditava suremuse oluline vähenemine),on nii mõndagi veel saavutada. Näiteks tuleks ületada suured erinevusedsotsiaal-majanduslike rühmade tervises, parandada elanikkonna kindlustuskatet,koostada põhjalik kava tööjõupuuduse lahendamiseks, pareminitegeleda kasvava hulga inimestega, kes põevad (mitut) mittenakkushaigust,ning paremini ära kasutada e-tervise süsteemi, eriti arstiabi integreerimiseksja kliiniliste otsuste tegemiseks. Kvaliteedi osas on tehtud suuri edusamme,kuid üldpilt on jätkuvalt ebaühtlane. Välditavate hospitaliseerimiste arv onüks Euroopa madalamaid astma ja kroonilise obstruktiivse kopsuhaigusepuhul, keskmine südamepuudulikkuse ja diabeedi puhul, kuid üks suuremaidkõrgvererõhktõve puhul. Lisaks on südameinfarkti ja insuldi 30-päevasesuremuse näitaja Eestis üks Euroopa halvimaid. Need tulemid viitavad sellele,et teenuste kvaliteedi ja ravi koordineerimise parandamiseks on veel paljuteha. Uuel rahvastiku tervise arengukaval, mis on praegu läbivaatamisel, ontulevaste reformide edukuses otsustav roll.

Estonia: health system review

This analysis of the Estonian health system reviews recent developments in organization and governance, health financing, health care provision, health reforms and health system performance. In 2017, the Estonian government took the historic step of expanding the revenue base of the health system,which has been a longstanding challenge. However, in terms of percentage of GDP it remains a small increase and long-term financial sustainability could still pose a problem. That said, if these additional funds are invested wisely, they could play a positive role in further improving the health system. Indeed, although Estonia has made remarkable progress on many health indicators (e.g. the strongest gains in life expectancy of all EU countries, strongly falling amenable mortality rates), there are opportunities for improvements. They include overcoming the large health disparities between socioeconomicgroups, improving population coverage, developing a comprehensive plan to tackle workforce shortages, better managing the growing number of people with (multiple) noncommunicable diseases and further reaping the benefits of the e-health system, especially for care integration and clinical decision-making. Also in terms of quality, large strides have been made but the picture is mixed. Avoidable hospital admissions are among the lowest in Europe for asthma and chronic obstructive pulmonary disease (COPD), about average for congestive heart failure and diabetes, but among the worst for hypertension. Moreover, the 30-day fatality rates for acute myocardial infarction and stroke are among the worst in the EU. These outcomes suggest substantial room to further improve service quality and care coordination. The new NHP, which is currently being revised, will play a crucial role in the success of future reform efforts.

Better noncommunicable disease outcomes: challenges and opportunities for health systems: Estonia: country assessment

This report reviews health system challenges and opportunities in Estonia to scale up core services for the prevention, early diagnosis and management of noncommunicable diseases. Outcomes of noncommunicable diseases have been improving and Estonia is closing the gap with other EU countries. In part this is due to progress implementing core population interventions such as tobacco control, prevention of harmful use of alcohol and improving nutrition and physical activity. The assessment recommends that to further strengthen the health system response to NCDs, Estonia should consider the following six areas: strengthening coordination and governance; introducing chronic disease management systems based on family medicine; accelerating action on obesity and nutritional risk factors for noncommunicable diseases; upgrading the e-health system into an integrated clinical and decision support system; empowering patients, and; analysing the case for change and refining plans for addressing noncommunicable diseases.

Out-of-pocket payments and health care utilization in Estonia, 2000–2012

This paper analyses out-of-pocket payments, their impact on catastrophic expenditures and impoverishment in Estonia from 2000 to 2012. Microdata from the Estonian Household Surveys collected by Statistics Estonia were used, complemented by utilization data from other studies. Statistical and econometric methods were applied. The results show that out-of-pocket expenditures peaked in 2006 and dropped thereafter. The decline is explained by the relative increase of pensions during the crisis years, promotion of generic drugs and reduced utilization of health care, especially dental care. Analysis of income-related inequalities in health care financing and utilization continues to show that for those services that are more dependent on out-of-pocket payments, there were either more inequalities in utilization, clearly demonstrated in adult dental care, or there was more risk of being pushed into poverty, such as in the case of spending on prescription and over-the-counter drugs by pensioners. Compared to previous studies, the impact of drug purchases on catastrophic expenditure has declined, which may be explained by both the changing attitudes towards cheaper drugs and increasing pensions relative to drug prices. Regarding the dental care, however, the picture is similar to earlier studies that high out-of-pocket payments cause low-income households to withdraw from the utilization of dental care services.

Estonia: health system review.

This analysis of the Estonian health system reviews recent developments in organization and governance, health financing, health-care provision, health reforms and health system performance. Without doubt, the main issue has been the 2008 financial crisis. Although Estonia has managed the downturn quite successfully and overall satisfaction with the system remains high, it is hard to predict the longer-term effects of the austerity package. The latter included some cuts in benefits and prices, increased cost sharing for certain services, extended waiting times, and a reduction in specialized care. In terms of health outcomes, important progress was made in life expectancy, which is nearing the European Union (EU) average, and infant mortality. Improvements are necessary in smoking and alcohol consumption, which are linked to the majority of avoidable diseases. Although the health behaviour of the population is improving, large disparities between groups exist and obesity rates, particularly among young people, are increasing. In health care, the burden of out-of-pocket payments is still distributed towards vulnerable groups. Furthermore, the number of hospitals, hospital beds and average length of stay has decreased to the EU average level, yet bed occupancy rates are still below EU averages and efficiency advances could be made. Going forwards, a number of pre-crisis challenges remain. These include ensuring sustainability of health care financing, guaranteeing a sufficient level of human resources, prioritizing patient-centred health care, integrating health and social care services, implementing intersectoral action to promote healthy behaviour, safeguarding access to health care for lower socioeconomic groups, and, lastly, improving evaluation and monitoring tools across the health system.

Estonia: health system review

This analysis of the Estonian health system reviews recent developmentsin organization and governance, health financing, health care provision,health reforms and health system performance.Without doubt, the main issue has been the 2008 financial crisis. AlthoughEstonia has managed the downturn quite successfully and overall satisfactionwith the system remains high, it is hard to predict the longer-term effects of theausterity package. The latter included some cuts in benefits and prices, increasedcost sharing for certain services, extended waiting times, and a reduction inspecialized care. In terms of health outcomes, important progress was made inlife expectancy, which is nearing the European Union (EU) average, and infantmortality. Improvements are necessary in smoking and alcohol consumption,which are linked to the majority of avoidable diseases. Although the healthbehaviour of the population is improving, large disparities between groupsexist and obesity rates, particularly among young people, are increasing. Inhealth care, the burden of out-of-pocket payments is still distributed towardsvulnerable groups. Furthermore, the number of hospitals, hospital beds andaverage length of stay has decreased to the EU average level, yet bed occupancyrates are still below EU averages and efficiency advances could be made. Goingforwards, a number of pre-crisis challenges remain. These include ensuringsustainability of health care financing, guaranteeing a sufficient level of humanresources, prioritizing patient-centred health care, integrating health and socialcare services, implementing intersectoral action to promote healthy behaviour,safeguarding access to health care for lower socioeconomic groups, and, lastly,improving evaluation and monitoring tools across the health system.

Case study on socially determined inequities in alcohol consumption patterns in Estonia

This alcohol and equity case study focuses on examining socially determined inequities in alcohol consumption patterns in Estonia. That is, it focuses on analysis of differences or differentials in social determinants that are considered to be avoidable, unfair and remediable – namely inequities. The analysis will provide an overview not only of the patterns of alcohol consumption and its impact, but also what alcohol interventions have been implemented in Estonia in the past and to what extent policy responses and structures in the country have reduced or increased inequities.

Costs, health effects and cost-effectiveness of alcohol and tobacco control strategies in Estonia.

OBJECTIVE: To assess the population-level costs, effects and cost-effectiveness of different alcohol and tobacco control strategies in Estonia. DESIGN: A WHO cost-effectiveness modelling framework was used to estimate the total costs and effects of interventions. Costs were assessed in Estonian Kroon (EEK) for the year 2000, while effects were expressed in disability-adjusted life years (DALYs) averted. Regional cost-effectiveness estimates for Eastern Europe, were used as baseline and were contextualised by including country-specific input data. RESULTS: Increased excise taxes are the most cost-effective intervention to reduce both hazardous alcohol consumption and smoking: 759 EEK (euro 49) and 218 EEK (euro 14) per DALY averted, respectively. Imposing additional advertising bans would cost 1331 EEK (euro 85) per DALY averted to reduce hazardous alcohol consumption and 304 EEK (euro 19) to reduce smoking. Compared to WHO-CHOICE regional estimates, interventions were less costly and thereby more cost-effective in Estonia. CONCLUSIONS: Interventions in alcohol and tobacco control are cost-effective, and broad implementation of these interventions to upgrade current situation is warranted from the economic point of view. First priority is an increase in taxation, followed by advertising bans and other interventions. The differences between WHO-CHOICE regional cost-effectiveness estimates and contextualised results underline the importance of the country level analysis.